{"id":"559174-7638","orgnr":"559174-7638","name":"RG Pharma Development AB","name_registered_on":"2018-10-10","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2018-10-10","business_description":"Bolaget avser att utföra konsulttjänster inom läkemedels- utveckling eller närliggande område. Vidare kan bolaget vara ägare av verksamhet inom läkemedelsbranschen eller närliggande område.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"street":"Eddagatan 6","care_of":"c/o Lars Olsson","postal_code":"75316","city":"UPPSALA","country":"SE","municipality":{"code":"0380","name":"Uppsala"},"county":{"code":"03","name":"Uppsala län"}},"registered_office":{"municipality":{"code":"0380","name":"Uppsala"},"county":{"code":"03","name":"Uppsala län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-09"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-06-12","documents":{"annual_report":"/v1/documents/10958836-4670-47bd-b9f6-5f2db66f4424.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/25_7.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-05-16","documents":{"annual_report":"/v1/documents/2c894021-1ec6-48ed-b782-4760bd6d46bc.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/20_6.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-03-08","documents":{"annual_report":"/v1/documents/8ad28640-1013-45b6-be0f-bfa692fbfa9c.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/11_3.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-05-26","documents":{"annual_report":"/v1/documents/4d4ae224-f412-4104-b4b8-235e049b8488.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/22_4.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-02-10","documents":{"annual_report":"/v1/documents/729d53a5-f317-4b5a-9bb9-21e51b773439.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/11_2.zip"}},{"from":"2020-01-01","to":"2020-12-31","framework":"K2","signed_on":"2021-02-15","documents":{"annual_report":"/v1/documents/155f5e0c-fd29-48fc-a4a7-d634ccaf1dbb.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/07_2.zip"}},{"from":"2018-10-10","to":"2019-12-31","framework":"K2","signed_on":"2020-02-26","documents":{"annual_report":"/v1/documents/60ea4280-8df4-48c8-a2c8-1621b35640f5.xhtml"},"source":{"dataset":"arsredovisningar","file":"2020/09_2.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"operating_profit":-21258,"profit_after_financial_items":-20885,"net_profit":-20885,"total_assets":314151,"current_assets":314151,"equity":304151,"share_capital":50000,"unrestricted_equity":254151,"current_liabilities":10000,"cash":241007,"equity_ratio":0.968,"net_sales_growth":-1,"source":{"annual_report":"2025-12-31","document":"/v1/documents/10958836-4670-47bd-b9f6-5f2db66f4424.xhtml"},"anchors":{"cash":{"text":"241 007","prefix":"Summa kassa och bank","suffix":"312 104"},"current_assets":{"text":"314 151","prefix":"omsättningstillgångar"},"current_liabilities":{"text":"10 000","prefix":"skulder"},"equity":{"text":"304 151"},"equity_ratio":{"text":"96,8"},"net_sales":{"text":"0","prefix":"Nettoomsättning"},"operating_profit":{"text":"21 258","suffix":"-12"},"profit_after_financial_items":{"text":"20 885"},"share_capital":{"text":"50 000","prefix":"utgång"},"total_assets":{"text":"314 151","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"254 151","suffix":"Styrelsen"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-06-12","signatories":[{"name":"L*****","role":"Styrelseledamot"}]}}